Market Tracker

11/21 6:05pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

8.52
Data as of Nov 21
 +0.10 / +1.19%
Today’s Change
6.88
Today|||52-Week Range
18.18
-43.16%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close8.42
Today’s open8.58
Day’s range8.40 - 8.60
Volume883,810
Average volume (3 months)1,241,488
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.15-2.71%
NVAXNovavax Inc+0.06+1.19%
IMGNImmunoGen Inc+0.16+1.65%
RLYPRelypsa Inc+0.78+3.40%
Data as of 3:59pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts